U.S. Appeals Court Won’t Rehear Lawsuit Over Medicare Payment Cuts for Hospitals’ 340B-Purchased Drugs
The full U.S. Court of Appeals for the District of Columbia Circuit late this afternoon denied a motion to reconsider a three-judge panel’s
…The full U.S. Court of Appeals for the District of Columbia Circuit late this afternoon denied a motion to reconsider a three-judge panel’s
…Activists aligned with the powerful grassroots group AIDS Healthcare Foundation (AHF) marched yesterday in front of drug manufacturer AstraZeneca’s Wilmington, Del., headquarters building to protest the company’s decision effective Oct.
…Some 340B covered entities report being unable to buy Sanofi covered outpatient drugs for their own pharmacies at discounted 340B prices in recent days, despite Sanofi’s assurances that its new limits
…(UPDATE Saturday Oct. 10, 2020, 9:20 a.m. EDT—The U.S. Health and Human Services Department (HHS) said
…The Republican chairman of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee and the
…A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today from Powers Law, based in Washington, D.C. We will have more information about 340B Report sponsorship packages for 2021 in
…(UPDATED Friday Oct. 2, 2020, 4:30 p.m. EDT)
A Republican U.S. congressman from rural central Pennsylvania
…A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today by Equiscript CEO Michael Burkhold. I encourage you to read it. We will have more information about 340B Report
…Only 30—less than 1 percent—of the 340B covered entities that drug manufacturer Merck wrote to this summer seeking their contract pharmacy claims data are sharing their data with Merck
…(Update 1, Friday Sept. 25, 1:00 p.m. EDT—Merck is “considering any next steps in our effort to ensure compliance with
…*Sign up for news summaries and alerts from 340B Report